In 2013, Cai and colleagues succeeded in transferring hybrid DNA containing BCR/ABL sequences encapsulated in chronic myelogenous leukaemia (CML) cell-derived MVs to human embryonic kidney (HEK293) cells and neutrophils [77]. Here, BCR is linked to chronic myelogenous leukemia, BCR-ABL1 positive.